Jonathan Silverstein Healthcare News

This is selected healthcare news for Jonathan Silverstein, which is filed under People. There are 21 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
8/23/2022 $20M from NIH Provides Infrastructure, Leadership for Project To Map the Human Body at the Cellular Level
... and analysis infrastructure to knit together the software tools and data produced by scientists in the HuBMAP consortium and the broader scientific community. HIVE IEC is co-led by the University of Pittsburgh's Jonathan Silverstein and Phil Blood of the Pittsburgh Supercomputing Center, a joint initiative between CMU and Pitt ...
cmu.edu
4/1/2020 Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
... are impressed by the progress Aspen has made to date against its goals to develop innovative therapies to treat Parkinson disease and encouraged by the broader investment community's support of the company," said Jonathan Silverstein , Managing Partner of OrbiMed. Aspen's lead product, ANPD001, is currently undergoing investigational new drug (IND ...
PR Newswire
7/31/2019 City Council has no financial analyst as crucial budget cycle approaches – Crain’s
... public-private partnerships and rating agency actions, and analyze how much legislative proposals will affect city coffers. Ben Winick, the office's sole director since 2015, departed on May 19, the mayor's office said. Jonathan Silverstein, COFA's legislative financial analyst, is now the lone employee in the office, which has a ...
Crain's Chicago Business
10/24/2017 NeuroPace Closes $74 Million Equity Funding to Accelerate Patient Access to the World’s First Brain-Responsive Neurostimulation System to Treat Epilepsy
... with partial (focal) onset seizures that are not well controlled by medication alone. “The outstanding clinical results obtained with the RNS System provide very compelling evidence to alter the epilepsy treatment paradigm,” said Jonathan Silverstein, J.D., OrbiMed Partner. “Even more exciting may be the unprecedented chronic EEG data captured by ...
Business Wire